{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:34:19Z","timestamp":1747168459032,"version":"3.40.5"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com.au","clinicalkey.com","nwhjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nursing for Women's Health"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.nwh.2020.05.008","type":"journal-article","created":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T04:00:56Z","timestamp":1594526456000},"page":"294-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lasmiditan Is a New Option for Acute Migraine Treatment"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9613-7532","authenticated-orcid":false,"given":"Kala K.","family":"Blakely","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelley","family":"Stallworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nwh.2020.05.008_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/head.13456","article-title":"The American Headache Society position statement on integrating new migraine treatments into clinical practice","volume":"59","year":"2019","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.nwh.2020.05.008_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","article-title":"Migraine","volume":"37","author":"Burch","year":"2019","journal-title":"Neurology Clinics"},{"issue":"4","key":"10.1016\/j.nwh.2020.05.008_bib3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/head.13281","article-title":"The prevalence and impact of migraine and severe headaches in the United States: Figures\u00a0and trends from government health studies","volume":"58","author":"Burch","year":"2018","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.nwh.2020.05.008_bib5","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/brain\/awz134","article-title":"Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine","volume":"142","author":"Goadsby","year":"2019","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.nwh.2020.05.008_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0333102419889350","article-title":"Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans","volume":"40","author":"Knievel","year":"2020","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/j.nwh.2020.05.008_bib7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1177\/0333102419855080","article-title":"Safety findings from phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN","volume":"39","author":"Krege","year":"2019","journal-title":"Cephalalgia"},{"issue":"24","key":"10.1016\/j.nwh.2020.05.008_bib8","doi-asserted-by":"crossref","first-page":"e2222","DOI":"10.1212\/WNL.0000000000006641","article-title":"Lasmiditan is an effective acute treatment for\u00a0migraine: A phase 3 randomized study","volume":"91","author":"Kuca","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nwh.2020.05.008_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-019-1032-x","article-title":"Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: Findings from SAMURAI and SPARTAN, two randomized phase 3 trials","volume":"20","author":"Loo","year":"2019","journal-title":"Journal of Headache and Pain"},{"key":"10.1016\/j.nwh.2020.05.008_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-019-1420-5","article-title":"Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: Findings from the phase 3 trials (SAMURAI and SPARTAN)","volume":"19","author":"Loo","year":"2019","journal-title":"BMC Neurology"},{"issue":"2","key":"10.1016\/j.nwh.2020.05.008_bib11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s13311-017-0592-1","article-title":"Migraine treatment: Current acute medications and their potential mechanisms of action","volume":"15","author":"Ong","year":"2018","journal-title":"Neurotherapeutics"}],"container-title":["Nursing for Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485120301021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485120301021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T17:10:09Z","timestamp":1741713009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751485120301021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1751485120301021"],"URL":"https:\/\/doi.org\/10.1016\/j.nwh.2020.05.008","relation":{},"ISSN":["1751-4851"],"issn-type":[{"type":"print","value":"1751-4851"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lasmiditan Is a New Option for Acute Migraine Treatment","name":"articletitle","label":"Article Title"},{"value":"Nursing for Women's Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nwh.2020.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AWHONN","name":"copyright","label":"Copyright"}]}}